CARIS LIFE SCIENCES, INC. Amortization of Debt Discount (Premium)
CARIS LIFE SCIENCES, INC. (CAI) reported Amortization of Debt Discount (Premium) of $298.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2026-06-30 was $298.00K, a 96.16% decline year-over-year.
- CARIS LIFE SCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2026-03-31 was $2.62M, a 34.91% increase year-over-year.
- CARIS LIFE SCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2025-12-31 was $605.00K, a 68.26% decline year-over-year.
- CARIS LIFE SCIENCES, INC. amortization of debt discount (premium) for the quarter ending 2025-09-30 was $2.46M, a 34.81% increase year-over-year.
- CARIS LIFE SCIENCES, INC. amortization of debt discount (premium) for fiscal 2025 was $12.77M, a 81.00% increase from fiscal 2024.
- CARIS LIFE SCIENCES, INC. amortization of debt discount (premium) for fiscal 2024 was $7.05M, a 31.16% increase from fiscal 2023.
- CARIS LIFE SCIENCES, INC. amortization of debt discount (premium) for fiscal 2023 was $5.38M.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $298.00K 10-Q · filed 2026-08-05 | $2.92M 10-Q · filed 2026-08-05 | $3.53M derived: sum of 3 quarters · filed 2026-08-05 | $5.99M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.62M 10-Q · filed 2026-05-08 | $3.23M derived: sum of 2 quarters · filed 2026-05-08 | $5.69M derived: sum of 3 quarters · filed 2026-05-08 | $13.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.07M derived: sum of 2 quarters · filed 2026-03-03 | $10.82M derived: sum of 3 quarters · filed 2026-08-05 | $12.77M 10-K · filed 2026-03-03 |
| 2025-09-30 | $2.46M 10-Q · filed 2025-11-05 | $10.22M derived: sum of 2 quarters · filed 2026-08-05 | $12.16M 10-Q · filed 2025-11-05 | $14.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $7.75M 10-Q · filed 2026-08-05 | $9.70M 10-Q · filed 2026-08-05 | $11.61M derived: sum of 3 quarters · filed 2026-08-05 | $13.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.95M 10-Q · filed 2026-05-08 | $3.85M derived: sum of 2 quarters · filed 2026-05-08 | $5.68M derived: sum of 3 quarters · filed 2026-05-08 | $7.41M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.73M derived: sum of 2 quarters · filed 2026-03-03 | $5.46M derived: sum of 3 quarters · filed 2026-03-03 | $7.05M 10-K · filed 2026-03-03 |
| 2024-09-30 | $1.83M 10-Q · filed 2025-11-05 | $3.56M derived: sum of 2 quarters · filed 2025-11-05 | $5.15M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $1.73M 10-Q · filed 2025-08-12 | $3.32M 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | $5.38M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |